drugset

drugset / Trial / NCT00000295

Progesterone Treatment in Female Smokers - 12

NCT00000295 ↗

Phase 2 Completed National Institute on Drug Abuse (NIDA) University of Minnesota · collab

CrossoverDouble-blindTreatment

Summary

The purpose of this study is to investigate progesterone effects in female smokers

Timeline

Start: 1999-04
Primary completion: —
Completion: 2001-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Progesterone	Other / unclassified	200 mg	—

Indications